- Total dose administered in milliliters, converted into 0.1 mL units for billing
no direct PubMed-indexed studies have measured cortisol levels following Semax administration Nasal Administration: Local irritation possible but typically mild Long-term Data: Decades of Russian clinical experience suggest good safety profile Selank Safety Profile: (PMID: 25176261, PMID: 28280289) Excellent Tolerability: Very few reported adverse events No Dependence Risk: Does not produce tolerance or withdrawalmajor advantage No Sedation: Unlike benzodiazepines, does not cause drowsiness or cognitive impairment No Muscle Relaxation: Anxiolytic effects without physical sedation Immunomodulatory Effects: May affect immune function
most can be stored at room temperature for a limited period after first use per product labeling
TB-500 has shown similar anti-inflammatory abilities in animal models
Oral capsule form is typically recommended for gut-focused treatment
The evidence was based on experimental data only briefly described in the patent and included models of: gastric ulcers, heart damage, liver damage, pancreatic injury, kidney damage, experimental diabetes, fever, edema, rhinitis, bone fracture, burns, skin wounds, hypersensitivity reactions, pupil dilation, colon injury, tumour growth, radiation injury, red blood cell development, fertility and lactation, tooth damage, several types of central and peripheral nerve damage, and survival from infection with Trichinosis (i.e., tapeworms) as well as several viruses